Caris Life Sciences nears $2 billion in whole funding for precision most cancers analysis
An Irving-based firm on a mission to treatment most cancers now has deeper pockets to faucet for improvement of its precision drugs expertise. Most cancers diagnostic analysis agency Caris Life Sciences stated Thursday it raised one other $400 million in debt financing backed by OrbiMed and Braidwell, two life science funding companies. Based in 2008, […]
Continue Reading